Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Achieving gender parity – designing clinical trials with women in mind

The importance of putting flexibility at the core of trials to make them more accessible for women

- PMLiVE

GDPR and events: what the pharma industry needs to know in 2025

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to applying GDPR principles at events and tradeshows. With...

Apex Events and Exhibitions

- PMLiVE

Using technology to make your exhibitions stand out in 2025

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement tactics. Exhibitions remain one of the most effective marketing channels for the pharmaceutical...

Apex Events and Exhibitions

- PMLiVE

Roche to advance Parkinson’s disease candidate into phase 3 development

More than ten million people worldwide are living with the neurodegenerative disorder

- PMLiVE

Novartis shares positive late-stage results for Fabhalta in rare blood disorder PNH

Paroxysmal nocturnal haemoglobinuria affects approximately ten to 20 people per million worldwide

- PMLiVE

FDA approves new presentation of Celltrion’s SteQeyma for paediatric psoriasis

The Stelara biosimilar now offers all dosage forms and strengths of its reference product

- PMLiVE

Bridging the gap: from awareness to action in health equity

The real challenge to achieving health equity lies in translating awareness into tangible action

- PMLiVE

Insights From ISPOR 2025: Breaking the Data Barrier in Rare Diseases – Can AI Bridge the Gap?

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and insights in health economics and outcomes research (HEOR) and market access. In...

Petauri Evidence

- PMLiVE

Medscape Education Celebrates 30 Years of Impact with Launch of The Center of Excellence for Instructional Design

Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of Excellence for Instructional Design—a central hub of expertise and strategic capability, dedicated to...

Medscape Education

- PMLiVE

Merck’s perioperative Keytruda regimen approved by FDA for head and neck cancer

More than 72,680 new cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

The deal will focus on advancing pre-clinical candidates for chronic conditions

- PMLiVE

Moderna’s RSV vaccine mRESVIA granted FDA approval to protect younger adults

The vaccine is already approved in the US for use in adults aged 60 years and older

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links